logo Synaptica
Organisationstyp: Bedrijf
Spezialisierung: Research & Development
Nummer der Handelskammer: 86029983


Toernooiveld 100
Synaptica Protein2

Synaptica develops computational neuroscience tools for epilepsy predictions. Ion channel dynamics and biologically realistic spiking neural networks can provide insights into how alterations in the molecular machinery relate to channelopathies such as epilepsy.

Contact us to request a demo!

Synaptica uses NEURON Simulator with NetPyNE.

Synaptica B.V. is a medical-scientific research and development company. Synaptica performs epilepsy calculations using biologically realistic spiking brain circuit models.

Synaptica is founded by Dr. Marijn Martens; Marijn graduated cum laude in 2010 with a Master’s degree in Cognitive Neuroscience from the Donders Graduate School for Cognitive Neuroscience. That year he obtained a TOPTalent NWO grant and used it to conduct his PhD research titled Emerging Brain Circuits within the Department of Neuroinformatics at the Donders Institute in Nijmegen. After his PhD in 2015, Marijn worked at startups where he focused on offering medical specialists tools for personalized diagnosis, prognosis and ultimately treatment based on (digital) biomarkers.

Bild von Helma van den Hurk

Ist dieses Unternehmen ein potenzieller Partner für Sie? Kontaktieren Sie bitte:

Helma van den Hurk Innovatiemanager